![Jerome Zeldis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jerome Zeldis
Directeur/Membre du Conseil chez
NEXGEL, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Dr. Jerome B. Zeldis is an Executive Chairman & Chief Medical Officer at ViralClear Pharmaceuticals, Inc., an Independent Director at NexGel, Inc., a Chairman at Trek Therapeutics PBC, an Independent Director at PTC Therapeutics, Inc., an Independent Director at Soligenix, Inc. and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Biond Biologics Ltd., NexGel, Inc., Immodulon Therapeutics Ltd., PTC Therapeutics, Inc., Soligenix, Inc., Castleman Disease Collaborative Network, Central New Jersey Council Boy Scouts of America, International Castlemans Disease Organization, Mali Health Organizing Project, PTC Corp.
and Semorex, Inc. Dr. Zeldis was previously employed as an Executive Vice President-Research & Development by NexImmune, Inc., an Independent Director by BioSig Technologies, Inc., a Chief Medical Officer by Celularity, Inc. (United States), a Chief Medical Officer by Sorrento Therapeutics, Inc., a Chairman by MetaStat, Inc., a Chairman by Alliqua BioMedical, Inc., an Independent Director by Bionor Pharma ASA, a Professor by Robert Wood Johnson Medical School, a Chief Medical Officer by Celgene Corp., a Chief Executive Officer by Celgene Global Health, an Associate Professor-Clinical by Weill Cornell Medical College, an Associate Professor by University of California, Davis, an Assistant Professor by Harvard Medical School, and an Associate Director by Sandoz Research Institute.
He also served on the board at AIT Therapeutics, Inc., Beyond Air Ltd., Kalytera Therapeutics, Inc., Kalytera Therapeutics, Inc. /Old/, IR Biosciences Holdings, Inc., Arthritis Foundation New Jersey Chapter, Etubics Corp., ImmuneRegen BioSciences, Inc. and The Arthritis Foundation.
He received his undergraduate degree from Brown University, a graduate degree from Brown University and a doctorate degree from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PTC THERAPEUTICS, INC. 0,03 % | 10/04/2026 | 22 500 ( 0,03 % ) | 2 M $ | 31/05/2026 |
NEXGEL, INC. 1,17 % | 03/06/2026 | 106 664 ( 1,17 % ) | 63 998 $ | 31/05/2026 |
| 20/06/2025 | 96 ( 0 % ) | 87 $ | 31/05/2026 |
Postes actifs de Jerome Zeldis
| Sociétés | Poste | Début |
|---|---|---|
| SOLIGENIX, INC. | Directeur/Membre du Conseil | 22/06/2011 |
| PTC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/09/2012 |
| NEXGEL, INC. | Directeur/Membre du Conseil | 01/04/2020 |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Develops treatments for cancer | Directeur/Membre du Conseil | 23/11/2017 |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Président | 01/04/2020 |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Directeur/Membre du Conseil | 01/06/2020 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
International Castlemans Disease Organization | Directeur/Membre du Conseil | - |
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Fondateur | 01/11/2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Jerome Zeldis
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jerome Zeldis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
39
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 39 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Soligenix, Inc.
 Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products | Health Technology |
IR Biosciences Holdings, Inc.
 IR Biosciences Holdings, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
BioSig Technologies, Inc.
 BioSig Technologies, Inc. Investment Banks/BrokersFinance Operates as an asset tokenization company that provides blockchain technology to tokenize gold and commodities | Finance |
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PTC Corp.
 PTC Corp. PTC Inc. is a custom computer programming services company that specializes in providing software solutions for product lifecycle management (Plm), computer-aided design (Cad), application lifecycle management (Alm), and service lifecycle management (Slm). The company's technologies are used by market leaders and disruptors across major manufacturing verticals, including auto, A&D, industrials, and life sciences. PTC Inc. is known for its collaborative approach, extensive partner network, and commitment to sustainability and social impact. The company is based in Needham, MA. | |
ImmuneRegen BioSciences, Inc.
 ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops immunomodulator to improve pulmonary function and stimulating the human immune system | Commercial Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semorex, Inc. | |
Central New Jersey Council Boy Scouts of America
 Central New Jersey Council Boy Scouts of America Miscellaneous Commercial ServicesCommercial Services Operates as volunteer organization to prepare young people to make ethical choices | Commercial Services |
The Arthritis Foundation
 The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Provides research, advocacy and support services for various kinds of arthritis and related diseases | Commercial Services |
Sandoz Research Institute | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Develops commercial prophylactic vaccines and immunotherapy products | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Develops treatments for cancer | Health Technology |
NexGel, Inc.
 NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Operates as a biomedical company | Health Technology |
Mali Health Organizing Project
 Mali Health Organizing Project Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that improves maternal and child health by supporting women, communities and community health system | Commercial Services |
MetaStat, Inc.
 MetaStat, Inc. Electrical ProductsProducer Manufacturing Develops cancer diagnostics technologies | Producer Manufacturing |
International Castlemans Disease Organization | |
Kalytera Therapeutics, Inc. /Old/
 Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops non-psychoactive cannabinoid medicines | Health Technology |
Beyond Air, Inc.
 Beyond Air, Inc. Medical SpecialtiesHealth Technology Developing a platform of nitric oxide generators and delivery systems | Health Technology |
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Manufactures medicines for infectious diseases | Health Technology |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Claritas Pharmaceuticals, Inc.
 Claritas Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops and commercializes therapies for patients | Health Technology |
Celgene Global Health | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Commercial Services |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Health Technology |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
Arthritis Foundation New Jersey Chapter
 Arthritis Foundation New Jersey Chapter Other Consumer ServicesConsumer Services Arthritis Foundation New Jersey Chapter is a company that operates in the Real Estate industry. The company is based in Iselin, NJ. | Consumer Services |
Castleman Disease Collaborative Network
 Castleman Disease Collaborative Network The private company is based in Paso Robles. The Castleman Disease Collaborative Network (CDCN) is a patient-founded nonprofit organization established in 2012 that focuses on accelerating research, improving treatment, and enhancing patient care for Castleman disease, a rare and complex group of inflammatory disorders. CDCN connects physicians, researchers, patients, and loved ones worldwide through online platforms, registries, forums, and summits to foster collaboration and scientific progress. The organization uses a community-driven approach to prioritize research questions, recruit scientists, and fund targeted studies, with a comprehensive research pipeline that includes patient enrollment, biospecimen collection, data analysis, and dissemination of findings. CDCN emphasizes drug repurposing and identification of new therapeutic targets, with clinical trials underway for treatments beyond the only FDA-approved drug for idiopathic multicentric Castleman disease. Key initiatives include the ACCELERATE natural history registry, the Castleman Disease Expert Panel, the IMCD Treatment Target Dashboard, and the Roadmap Project for drug repurposing. CDCN provides resources for patients, physicians, and researchers, such as toolkits, referral lists, support networks, educational materials, and regular updates. |
